Corebridge Financial’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,101	Closed	-$18.1K	–	1711
2025 Q1	$18.1K	Sell	2,101 -155	-7%	-$1.33K	﹤0.01%	2918
2024 Q4	$80.6K	Sell	2,256 -170	-7%	-$6.08K	﹤0.01%	2652
2024 Q3	$115K	Sell	2,426 -15	-0.6%	-$709	﹤0.01%	2547
2024 Q2	$123K	Buy	+2,441	New	+$123K	﹤0.01%	2478